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Abstract
Pregnancy and lactation deplete nutrients essential to the neurotransmission system. This may be one reason for the increased risk of depression during the
perinatal period. The objective of the present review was to systematically review the literature and summarise evidence on whether blood nutrient levels
inﬂuence the risk of perinatal depression. PubMed, EMBASE and CINAHL databases were searched for studies of any design. A total of twenty-four
articles of different designs were included, representing 14 262 subjects. We extracted data on study population, depression prevalence, nutrients examined,
deﬁciency prevalence, timing of assessment, reporting, analysis strategy and adjustment factors. In all, fourteen studies found associations of perinatal
depression with lower levels of folate, vitamin D, Fe, Se, Zn, and fats and fatty acids, while two studies found associations between perinatal depression
and higher nutrient levels, and eight studies found no evidence of an association. Only ten studies had low risk of bias. Given the methodological limitations
and heterogeneity of study approaches and results, the evidence for a causal link between nutritional biomarkers and perinatal depression is still inconclu-
sive. High-quality studies in deﬁcient populations are needed.
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Introduction
Perinatal depression, also referred to as maternal depression,
can occur during pregnancy or up to 1 year postpartum. It
is considered the most common complication of pregnancy.
In their systematic review of perinatal depression, Gavin
et al.(1) reported a pooled point prevalence of 11 % for
minor depression during pregnancy and 13 % for postpartum
depression in high-income countries. Early studies reported
differing levels of perinatal depression in low-income and
middle-income countries (LMIC), but the current literature
shows that prevalence is consistently higher than in high-
income countries(2). This is thought to be concomitant with
or exacerbated by poverty, gender inequity, anxiety, and famil-
ial and political instability(3,4). In a systematic review focusing
on LMIC, pooled prevalence for depressive symptoms was
16 % in the antenatal period (from thirteen studies), and
20 % in the postpartum period (from thirty-four studies)(5).
Perinatal depression can have serious and long-term
adverse effects on women and their children, and is therefore
gaining attention in the international health community(2,6–8).
Consequences for women include poor self-care, compro-
mised care-giving and increased morbidity from other causes,
while for children, malnutrition, poor physical and cognitive
development and increased illness have been reported(9–12).
Strategies to address perinatal depression are, however, less
clear, ranging from pharmacological treatment to commu-
nity-based support mechanisms and general poverty allevi-
ation, and focus primarily on treatment, rather than on
prevention(4,13).
Various biologically plausible pathways between nutrient
levels and depression have been suggested(14). Many essential
nutrients, or compounds derived from such nutrients, are
required for the synthesis of neurotransmitters and their
modulation, and may therefore be involved in mood
Abbreviations: CES-D, Center for Epidemiological Studies Depression Scale; EPDS, Edinburgh Postpartum Depression Scale; LMIC, low-income and middle-income
countries; RCT, randomised controlled trial.
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regulation(15,16). The biochemical role of nutrients in the
nervous system is described in detail elsewhere(14,15,17).
Pregnancy and lactation place additional demands on a
woman’s body, and therefore nutrient deﬁciencies arise more
easily during this time. Deﬁciency of nutrients during this crit-
ical period therefore may contribute to the increased risk of
depression during the perinatal period. Hormonal shifts and
lifestyle changes may in themselves increase the risk of peri-
natal depression, but may also contribute to changes in nutri-
ent levels and could thus act through that pathway(18).
Previous reviews limited the measures of nutritional
status to one speciﬁc nutrient or class of nutrients, such as
PUFA(19). Some explored depression in general (not limited
to the perinatal period), and others were not systematic(17,20).
One review on nutrient supplementation mixed prevention
(in previously undiagnosed women) and treatment (in
women already diagnosed with depression)(21). The present
review includes published evidence on any nutrient, but the
available studies focus on only a few out of the many import-
ant nutrients and phytochemicals that may be associated with
perinatal depression.
Objective
We initially designed the present review to summarise the
existing evidence from all analytical studies available on the
association between nutritional status and perinatal depression
in women. The results of the search highlighted two main ways
to capture nutritional status: through blood levels (i.e. biomar-
kers) and through dietary intake measures, each with their par-
ticular strengths. Biomarkers are a precise, direct measure of
nutritional status that account for bioavailability, while dietary
intake data can easily capture a larger panel of nutrients and
study the effect of whole diets, thus considering complex
food interactions. Studies measuring dietary intake have been
published in a separate review(22). The present review focuses
on nutritional biomarkers and their link to perinatal
depression.
Methods
Search strategy
We searched PubMed, EMBASE and CINAHL databases
from 1966 to 1 June 2016 for publications in English. We
used both medical subject heading terms and free text key-
words in two separate searches to identify all relevant studies.
The ﬁrst search combined nutrition terms with maternal
depression terms, while the second combined nutrition
terms with depression terms and maternity terms separately
(Fig. 1). All titles and abstracts identiﬁed by the search were
screened by two independent researchers who then reviewed
the full text of potentially eligible articles for inclusion.
Eligibility
We considered articles eligible if they were peer-reviewed and
presented measures of association between nutritional
biomarkers during or after pregnancy, and depression during
pregnancy or up to 1 year postpartum. Analytical studies of
any design were eligible for inclusion.
We included studies that evaluated nutritional biomarker
levels using blood analysis. We excluded supplementation
studies unless blood levels of nutrients were directly compared
against perinatal depression. Studies that assessed hormones
or other compounds synthesised by the body but not directly
affected by dietary intake were not included.
We excluded studies in women who were already diagnosed
with depressive symptoms or had other underlying health
problems (e.g. HIV). Studies had to assess perinatal de-
pression through a validated depression screening tool (i.e.
Edinburgh Postpartum Depression Scale (EPDS); Center for
Epidemiologic Studies Depression Scale (CES-D); Beck
Depression Inventory; Mini International Neuropsychiatric
Interview; twenty-item Self-Reporting Questionnaire; ten-item
Kessler Psychological Distress Scale; Goldberg’s Depression
Scale; Symptom Checklist-90-R, or Kitgum Maternal Mood
Scale; Postpartum Depression Screening Scale) or through
clinical diagnosis from a trained interviewer; though we also
allowed prescription of antidepressants as a proxy for a clinical
diagnosis. Two common tools used to screen for depression,
the CES-D and the Beck Depression Inventory, have often
been used in pregnancy and postpartum as they do not empha-
sise somatic symptoms such as appetite changes and sleep dis-
turbance. They have been found accurate in screening for both
minor and major depression(23). The only screening tools that
totally exclude somatic symptoms and are technically validated
for the pregnancy and postpartum period are the EPDS and
the Postpartum Depression Screening Scale. These have
higher sensitivity than other tools(24,25) and we therefore
assigned a lower risk of bias to studies using these tools.
Risk of bias assessment
In order to assess the methodological quality of each study, the
Cochrane Collaboration tool(26) was used to evaluate the risk
of bias in the randomised controlled trials (RCT), while
Fig. 1. Search strategy. MeSH, medical subject headings; ti/ab, title or
abstract.
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observational studies were evaluated using a modiﬁed version
of the Quality in Prognostic Studies (QUIPS) tool(27). Two
reviewers independently ranked each study as having high,
medium/unclear or low risk of bias in each domain of the
respective tools. The reviewers compared scores, disagree-
ments were discussed and a consensus reached.
The Cochrane tool comprises the following six domains:
random sequence generation (selection bias), allocation con-
cealment (selection bias), blinding of participants and person-
nel (performance bias), blinding of outcome assessment
(detection bias), incomplete outcome data (attrition bias),
and selective reporting (reporting bias).
While the QUIPS tool is designed to evaluate bias in prog-
nostic studies, ‘risks’ in epidemiology are similar to ‘progno-
ses’. It comprises six domains: study participation, study
attrition (replaced by response in cross-sectional studies and
by selection of controls in the two case–control studies), prog-
nostic factor (exposure) measurement, outcome measurement,
confounding, and statistical analysis and reporting. Further
details are provided in Supplementary Appendix S1.
Data extraction and synthesis
We used a standard form to extract characteristics and overall
results from all included studies (Table 1). We also extracted
information on the type of analysis performed and detailed
results for all studies (Supplementary Appendix 2, Tables
S1–S4). Studies that examined both B vitamins and Fe biomar-
kers are described in the two respective categories in the text,
but presented as their own group in the tables in order to
avoid duplication. Studies examined many different nutrients
and their timing of exposure and outcome assessment varied
widely. More importantly, several studies only reported linear
depression outcomes (as opposed to the appropriate categor-
ical outcome for screening tools), which precluded performing
a meta-analysis of associations between nutritional biomarkers
and perinatal depression without access to the original data.
We therefore present a descriptive summary of the results
and methodological quality of all included studies.
Results
Study inclusion and characteristics
From three databases, 5544 articles were identiﬁed after
removing duplicates. Titles and abstracts were screened and
178 full-text articles were retrieved and checked against inclu-
sion criteria. A total of thirty-ﬁve articles that used diet or
intake measures to assess nutritional status were reviewed sep-
arately(22), while four articles ﬁt inclusion criteria and were
included in both reviews. We ﬁnally included twenty-four arti-
cles in this review, representing 14 262 participants from six-
teen mainly high-income countries (Fig. 2).
Studies were grouped in four categories according to the
nutrients measured: (1) vitamins (four B vitamin studies –
two of which also included Fe and are presented in that cat-
egory as well, and ten vitamin D studies); (2) minerals (ﬁve
Fe studies, one Se study and one Zn and Mg study); (3) fat
and fatty acids (three studies assessing PUFA and one asses-
sing lipoproteins and cholesterol); and (4) several essential
nutrients (one study assessing major essential nutrients
grouped by principal components analysis). In terms of
study population, ﬁve studies used population-based prospect-
ive cohorts, seventeen recruited participants from hospitals or
clinics, one was a population-based convenience sample(28),
and one was a baseline assessment of an RCT(29).
Of the studies, three used the Structured Clinical Interview
for Diagnostic and Statistical Manual of Mental Disorders, 4th
edition (DSM-IV) Diagnoses (SCID-CV), and twenty used a
screening tool, most commonly the EPDS (ﬁfteen studies)
or the CES-D (three studies). One study used ﬁlling a pre-
scription for antidepressants as a proxy for clinical diagnosis.
Most studies reported a prevalence of perinatal depression
between 10 and 30 %, consistent with literature reviews(10,30).
Five studies found a depression prevalence over 30 % in
their populations, of which three over 40 %(31–33), while
three studies reported prevalences lower than 10 %(34–36).
Two studies failed to report depression prevalence and
another two could not estimate it as they used a case–control
design(28,37–39).
Of the twenty-four included studies, sixteen reported the
prevalence of nutrient deﬁciency for their nutrient of interest.
Five reported that either none or a very small percentage (<5 %)
of their study population was deﬁcient(28,31,40–42). Interestingly,
the eight studies that found no association between nutritional
biomarkers and perinatal depression included those ﬁve, and
one further study that did not report its nutrient deﬁciency
prevalence(32).
The reported prevalence of nutrient deﬁciency was highest
in the ten vitamin D studies. Using a common cut-off for
vitamin D deﬁciency of 20 ng/ml and converting nmol/l to
ng/ml, deﬁciency in the study populations ranged from
24 %(43) to 85 %(44). In ﬁve studies examining Fe and
Fe-deﬁciency anaemia, two (one American and one Korean)
reported no deﬁciency or anaemia(28,31), while a study from
India reported 30 % anaemia prevalence, based on Hb con-
centrations, without assessing ferritin concentrations or other
markers that differentiate Fe-deﬁciency anaemia from other
forms(29). Another found 14 % Fe deﬁciency and 25 % Fe
depletion in a Spanish population(36). One Japanese study on
Fe did not present the prevalence of deﬁciency(32). A
Norwegian group suggested that being at <5 % of the
omega-3 PUFA index could be indicative of a biological deﬁ-
ciency. Their population was categorised into percentiles, and
28 % (12/43) subjects were at or below 5·1 % of the PUFA
index, which they hypothesise indicates deﬁciency in fatty
acids(35). Eight studies did not report whether there were nutri-
tional deﬁciencies in their populations.
Risk of bias assessment
All studies had potential sources of bias in at least one domain.
We present the risk of bias of the ﬁve cross-sectional and two
case–control studies in Fig. 3, and of the sixteen cohort studies
in Fig. 4. Since there was only one RCT, we describe it in the
text.
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Table 1. Summary of studies evaluating associations between nutrients and perinatal depression*†‡§||
Study characteristics Exposure Outcome Results
First author (year) Country (cohort) n Study design
Depression
prevalence
Nutritional
deficiency Nutrients analysed Exposure definition Time assessed Tool; cut-point Time assessed
Adj.
model
Protective
associations
B vitamins
Blunden (2012)(41) UK (Southampton
Women’s Survey)
2856 Cohort 32 % 0·3 % Folate Mean nutrient
levels
1st trimester EPDS; 13 PP: 6 months,
1 year
No None
Chong (2014)(34) Singapore 709 Cohort 7 % preg,
10 % PP
Not reported Folate and
vitamin B12
Mean nutrient
levels, quartiles of
nutrient levels
3rd trimester EPDS; 15
preg, 13 PP
3rd trimester,
PP: 3 months
Yes High v. low folate
levels; only in
antenatal period
Vitamin D
Accortt (2016)(44) USA (DOMInO
trial)
91 Cohort 12 % 85 % ≤20 ng/ml Vitamin D Linear nutrient
levels
1st trimester EPDS,
continuous
PP: 4–6
weeks
Yes None (high v. low
levels of vitamin D
as linear trend
borderline
significant)
Brandenbarg
(2012)(46)
Netherlands
(Amsterdam Born
Children and Their
Development
(ABCD) study)
4101 Cohort 28 % 44 % ≤20 ng/ml Vitamin D Deficient,
insufficient,
sufficient, and
normal
1st trimester CES-D; 16 2nd trimester Yes Normal and
sufficient v. low
levels of vitamin D,
linear trend
Cassidy-Bushrow
(2012)(33)
USA (DOMInO
trial)
178 Cohort 42 % 83 % ≤20 ng/ml Vitamin D Linear nutrient
levels
1st trimester CES-D; 16 2nd trimester Yes High v. low levels of
vitamin D as linear
trend
Fu (2015)(49) China 213 Cohort 12 % 83 % ≤20 ng/ml Vitamin D Deficient,
insufficient and
normal
PP: 48 h EPDS; 12 PP: 3 months Yes High v. low levels of
vitamin D
Gould (2015)(45) Australia 1040 Cohort (in
PUFA RCT)
10 % 42 % ≤20 ng/ml Vitamin D Three nutrient
levels
PP: 48 h EPDS; 12 PP: 6 weeks,
6 months
Yes None (high v. low
levels of vitamin D
only in control group
at 6 weeks)
Gur (2014)(48) Turkey 189 Cohort 24 % at 6
months
40 % ≤20 ng/ml Vitamin D Normal, mild
deficiency and
severe deficiency;
means; linear
2nd trimester EPDS; 12 PP: 1 week, 6
weeks, 6
months
No High v. low levels of
vitamin D
Murphy (2010)(50) USA 97 Cohort 12 % 58 % ≤32 ng/ml Vitamin D Insufficient v.
sufficient
PP: each
month for 1–7
months
EPDS; 9 PP: each
month for 1–7
months
Yes Sufficient v.
insufficient levels of
vitamin D
Robinson (2014)(43) Australia (Raine:
Western Australian
Pregnancy Cohort
Study)
796 Cohort 19 % 24 % <19 ng/ml Vitamin D Quartiles of nutrient
levels
2nd trimester Shortened
EPDS; 6
PP: 3 d Yes High v. low levels of
vitamin D
Huang (2014)(42) USA 498 Cross-
section
12 % 4 % ≤20 ng/ml Vitamin D Quartiles and linear
trend of nutrient
levels
2nd trimester DASS-21,
PHQ-9; linear
2nd trimester Yes None
Nielsen (2013)(38) Denmark (Danish
National Birth
Cohort)
1480 Case–control N/A Not reported Vitamin D Six nutrient levels 3rd trimester Prescription
filled without
admission
Within 1 year Yes Normal v. high
levels of vitamin D
Fe and B vitamins
Lukose (2014)(29) India 365 Cross-
section
(baseline of
RCT)
33 % 30 % anaemic Hb, complete
blood count,
erythrocyte DW,
vitamin B12, Hcy,
MMA, folate
Low v. normal
nutrient levels
1st trimester K-10; 6 1st trimester Yes Anaemia v. no
anaemia
Watanabe
(2010)(32)
Japan 86 Cross-
section
62 % Not reported Folate, Hcy, total
protein, albumin,
Fe, Hb, Hct
Mean nutrient
levels, low v. high
concentrations of
folate and Hcy
1st trimester CES-D; 16 1st trimester Yes None
4
journals.cam
bridge.org/jns
Downloaded from https://www.cambridge.org/core. London School of Hygiene & Tropical Medicine, on 05 Feb 2018 at 14:08:34, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/jns.2017.58
Fe
Albacar (2011)(36) Spain 729 Cohort 9 % major
depression
Fe depletion: 25
%, Fe
deficiency: 14 %
Fer, transferrin,
free TfS, CRP
Fe depletion,
marginal Fe
depletion, Fe
deficiency
PP: 48 h SCID-CV 48 h, 8 weeks,
32 weeks
Yes Ferritin levels above
Fe deficiency and
Fe depletion
v. below
Aubuchon-Endsley
(2012)(28)
USA 82 Cross-
section
Not
reported
No deficiency Hb, sTfR, Fer,
AGP
Mean nutrient
levels
PP: 3 months SCL-90-R;
mean and SD
PP: 3 months No None
Bae (2010)(31) Korea 114 Cross-
section
43 % No anaemia Leucocytes,
erythrocytes, Hb,
Hct, MCV, MCH,
MCHC,
erythrocyte DW,
platelets, PDW,
MPV
Mean nutrient
levels. No cut-offs
Pregnancy BDI; 10 Pregnancy No None
Se
Mokhber (2011)(37) Iran 166 RCT Not
reported
Not reported Se v. placebo Randomised;
supplementation
during pregnancy
N/A EPDS; mean
difference
PP: 0–8
weeks
N/A Se supplementation
v. no
supplementation
Zn and Mg
Wójcik (2006)(47) Poland 66 Cohort (all
supplement)
3 d PP:
42 %, 30 d
PP: 29 %
Not reported Zn and Mg Mean nutrient
levels
PP: 3 d, 30 d EPDS; 10 PP: 3 d, 30 d No High v. low levels of
Zn
Fats and fatty acids
Markhus (2013)(35) Norway 43 Cohort 7 % 28 % ≤5·1 on
omega-3 index
DPA, DHA,
omega-3 index,
n-6:n-3 ratio, total
HUFA score, and
n-3 HUFA score
Mean nutrient
levels and quartiles
of nutrients
3rd trimester EPDS; 10 or
continuous
PP: 3 months,
6 months, 12
months
No High v. low omega-
3 index scores
Pinto (2017)(51) Brazil (Mental
Health and
Nutritional Status
During Pregnancy
and Postpartum)
172 Cohort 23 %
(average of
three
trimesters)
Not reported ALA, EPA, DPA,
DHA, LA, AA, γ-
LA, EDA, ETE,
total n-6:n-3 ratio
Mean nutrient
levels. No cut-offs
1st, 2nd and
3rd trimesters
EPDS; 11 1st, 2nd and
3rd trimesters
Yes High v. low n-3
PUFA levels; low v.
high total n-6:n-3
ratio
Teofilo (2014)(52) Brazil (Mental
Health and
Nutritional Status
During Pregnancy
and Postpartum)
238 Cohort 22 % (2nd
and 3rd
trimesters)
Not reported TAG, total
cholesterol, LDL,
HDL
Mean nutrient
levels. No cut-offs
1st, 2nd and
3rd trimesters
EPDS; 11 1st, 2nd and
3rd trimesters
Yes High v. low HDL
concentration
Rees (2009)(39) Australia 38 Case–control N/A Not reported n-3 PUFA, DHA,
EPA, ALA, n-6
PUFA, LA, AA,
DPA, n-6:n-3
ratio, AA:EPA
and DHA:DPA
High v. low nutrient
levels
3rd trimester EPDS; 13,
SCID-CV
3rd trimester Yes High v. low total n-3
content, DHA and
n-6:n-3 ratio
All nutrients
Bodnar (2012)(40) USA
(Antidepressant
Use During
Pregnancy (ADUP)
Study)
135 Cohort 22 % ‘Population was
well-nourished’
AA, EPA, DHA,
folate, Hcy,
vitamin C, vitamin
D, vitamin A and
carotenoids,
vitamin E, Fer
and sTfR
Tertiles of factors
identified with PCA:
EFA,
micronutrients,
carotenoids
1st or 2nd
trimester
SCID-CV 2nd or 3rd
trimester
Yes None
* Statistical terms: Adj. model, statistical analysis adjusted for potential confounding factors; N/A, not applicable; PCA, principal components analysis; RCT, randomised control trial.
† Depression terms: BDI, Beck Depression Inventory; CES-D, Center for Epidemiological Studies Depression Scale; DASS-21, Depression, Anxiety, and Stress Scales; EPDS, Edinburgh Postpartum Depression Scale; K-10, Kessler Depression
Scale; PHQ-9, Patient Health Questionnaire Depression Module; PP, postpartum; preg, pregnancy; SCID-CV, Structured Clinical Interview; SCL-90-R, Symptom Checklist-90-Revised.
‡ Fe and blood terms: AGP, inflammatory marker 1-acid glycoprotein; CRP, inflammatory marker C-reactive protein; DW, distribution width; Fer, ferritin; Hct, haematocrit; MCH, mean corpuscular Hb; MCHC, mean corpuscular Hb concentration;
MCV, mean corpuscular volume; MPV, mean platelet volume; PDW, platelet distribution width; sTfR, soluble transferrin receptors; TfS, free Fe and transferrin saturation.
§ Vitamins and minerals: A, retinol; B12, cobalamin; C, ascorbic acid; D, serum 25-hydroxyvitamin D; EFA, essential fatty acids; Hcy, homocysteine; MMA, methylmalonic acid.
ǁ Fatty acid terms: AA, arachidonic acid; ALA, α-linolenic acid; EDA, eicosadienoic acid; ETE, eicosatrienoic acid; HUFA, highly unsaturated fatty acids; LA, linolenic acid.
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All of the cross-sectional and case–control studies had
unclear or medium to high risk of bias in at least two domains,
often because they failed to report crucial information. The
domains ‘exposure measurement’ and ‘statistical analysis and
reporting’ were those with the lowest risk of bias. Outcome
measurement and confounding were most problematic, with
only one study considered at low risk of bias in each of
these domains. Even in adjusted models, four out of seven
studies did not include important confounders.
The sixteen cohort studies had low risk of bias in exposure
measurement, with one study using umbilical cord blood
instead of maternal venous blood(45). Outcome measurement
introduced little bias for this study design; only two studies
had medium risk of bias for using the CES-D as a screening
tool(33,46). Eleven out of sixteen cohort studies had a low
risk of bias in study participation, whereas ﬁve studies had
potential bias in their sampling and selection of participants.
Study attrition was the domain with the highest risk of bias,
with only three studies having low risk of bias. Three cohort
studies lost about half of their study population to
follow-up(35,37,44,47). Of the eleven studies with over 10 %
loss to follow-up, six failed to analyse differences between
completers and non-completers, which meant they had high
risk of bias in this domain. Only eight of sixteen studies
adequately adjusted for confounders, while the remainder
had a medium or high risk of bias due to their failure to
account for variables such as history of depression, social or
marital support, or basic demographic factors. Finally, in the
domain of statistical analysis and reporting, twelve of the six-
teen cohort studies had a low risk of bias as they clearly pre-
sented adjusted models with effect estimates, two studies had
medium risk of bias for unclear reporting, and two others were
considered at high risk of bias for failure to present adjusted
models. The RCT by Mokhber et al.(37) had low performance
and detection bias, medium risk of selection and reporting
bias, and high risk of attrition bias, with only 51 % of partici-
pants completing the trial.
Results from studies
Fourteen studies reported protective effects from higher (v.
lower) nutrient levels (B vitamins, vitamin D, Fe, Se, Zn and
PUFA): one cross-sectional study, one case–control study,
Fig. 2. Flowchart for inclusion of studies.
Fig. 3. Risk of bias assessment results for cross-sectional studies and case–
control studies. * Case–control studies; +, low risk of bias; ?, unclear risk of
bias; –, high risk of bias. 6
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eleven cohort studies and one RCT (see Table 1), three of
which did not present an adjusted analysis(35,47,48). Two studies
found that higher nutrient levels were associated with higher
risk of depression(29,38). Eight studies, four cohort and four
cross-sectional, found no statistically signiﬁcant association
between nutrient levels studied and perinatal depression in
their main analysis (Table 1). All studies are described below
in four categories, according to the nutrient groups examined.
Vitamins (Supplementary Appendix S2, Table S1). There was
little evidence for any association between folate or vitamin
B12 and perinatal depression from the four included studies.
Of the four studies, three had low risk of bias in at least
three of the six domains(29,34,41). Chong et al.(34) examined
folate and vitamin B12 in a cohort in Singapore in the third
trimester of pregnancy and measured depression at baseline
and at 3 months postpartum. Vitamin B12 was not
associated with depression at either time point. Increased
folate levels were protective against depression in the
antenatal assessment (OR 0·69 per standard deviation
increase (95 % CI 0·52, 0·94); P = 0·02). However, at 3
months postpartum when including the antenatal depression
score in the model, the relationship was weaker and no
longer signiﬁcant (OR 0·84 (95 % CI 0·62, 1·12); P = 0·25).
An English cohort study assessed whether folate levels in
the ﬁrst trimester were related to depression at 6 and 12
months postpartum and found no association at either time
point(41). In two cross-sectional studies, one from India and
one from Japan, researchers found no association between B
vitamins and perinatal depression(29,32).
Evidence of a protective effect on perinatal depression was
stronger for vitamin D, but not entirely consistent. Out of ten
studies on the topic, four did not ﬁnd a signiﬁcant protective
association in their main analysis (one had high risk of bias in
several domains, one hadmedium risk of bias in several domains
and one had low risk of bias in most domains). One study found
no association(42) and a small cohort study with high loss to
follow-up found a borderline protective association (log-
transformed continuous vitamin D levels, per unit: β =−0·21;
P= 0·06)(44). A large Australian study, within a PUFA trial,
found no association overall, but within the control group at 6
weeks postpartum, vitaminD levels in cord bloodwereprotective
against depression (reference: <10 ng/ml; 10·1–20 ng/ml: risk
ratio 0·35 (95 % CI 0·17, 0·69); >20 ng/ml: risk ratio 0·24 (95
% CI 0·12, 0·51)), with strong evidence for the interaction
with treatment (P = 0·006)(45). A Danish case–control study
with low risk of bias reported that higher levels of vitamin D
were associated with more depression(38).
The other six vitamin D studies not only reported protective
associations but found linear trends between vitamin D con-
centrations and depression. A study from the Netherlands
reported that for each 10 nM decrease in vitamin D concentra-
tion, there was a 5 % increase in risk of depressive symptoms,
and for the most deﬁcient category (≤29·9 nmol/l; ≤11·9 ng/ml),
the adjusted OR was 1·48 (95 % CI 1·13, 1·95)(46). This study
had moderate risk of bias in three domains and low risk of
bias in three domains. A Chinese cohort study with low risk
of bias in ﬁve of six domains found a protective effect of vita-
min D levels on postpartum depression (OR 0·81 (95 % CI
0·70, 0·92); P < 0·001)(49). Two small studies, one Turkish
and one American, both with high risk of bias in at least
one domain, found higher vitamin D levels to be protective
against depression(48,50). Lastly, Robinson et al.(43) in an
Australian cohort used a shortened EPDS and found that
women in the lowest quartile of vitamin D levels (<18·8 ng/ml,
similar to the deﬁciency level of<20 ng/ml) were at higher
risk of depression at 3 d postpartum (OR 2·19 (95 % CI
1·26, 3·78); P = 0·006). This study ranked as having low risk
of bias in ﬁve of six domains.
Minerals (Supplementary Appendix S2, Table S2). Only one
study assessed the relationship between Fe biomarkers and
perinatal depression longitudinally. In a Spanish cohort with
Fig. 4. Risk of bias assessment results for cohort studies. +, Low risk of bias;
?, unclear risk of bias; –, high risk of bias.
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low risk of bias, Albacar et al.(36) showed that Fe deﬁciency
(ferritin <7·26 µg/l) and Fe depletion (ferritin <12 µg/l)
were both associated with higher odds of developing
postpartum depression at 32 weeks (Fe deﬁciency: OR 3·73
(95 % CI 1·84, 7·56), P < 0·001; Fe depletion: OR 2·30
(95 % CI 1·29, 4·10), P = 0·005).
An American study and a Korean study examined Fe bio-
markers and perinatal depression using cross-sectional designs
and both generally had a high risk of bias. Neither study found
protective associations of Fe (the ﬁrst did not report deﬁcien-
cies and the latter found no clinical anaemia) or presented an
adjusted model(28,31). Two further cross-sectional studies
examined Fe levels and depression in the ﬁrst trimester (and
also included B vitamin biomarkers). Watanabe et al.(32) in
Japan found no associations, and Lukose et al.(29) in India
found that anaemia was protective against depression in the
ﬁrst trimester (adjusted prevalence ratio 0·67 (95 % CI 0·47,
0·96); P= 0·03). The study by Lukose et al.(29) was considered
as having moderate risk of bias in three domains and low risk
of bias in three domains, and Watanabe et al.(32) only achieved
a low risk of bias score in two of six domains.
A research team from Iran conducted a randomised trial
supplementing women daily with Se for 6 months of preg-
nancy. They showed signiﬁcantly higher Se blood levels and
on average two points lower EPDS scores in the supplemen-
tation group (supplementation mean EPDS score: 8·8 (SD 5·1)
v. placebo EPDS score: 10·7 (SD 4·4); P< 0·05)(37). This study,
however, had a high risk of bias due to incomplete outcome
data (51 % completion) and unclear risk of bias in three
other domains. Lastly, a team in Poland enrolled a small
cohort of pregnant women (n 66), supplemented them with
Zn and Mg and found a weak linear correlation between
EPDS scores and Zn blood levels (r –0·2968; P= 0·01), but
not Mg blood levels(47). No adjusted model or effect size
was reported and the study had high risk of bias in four out
of six domains.
PUFA and fat (Supplementary Appendix S2, Table S3). Three
studies examined relationships between PUFA biomarkers and
perinatal depression. A Brazilian cohort study showed that
high v. low n-3 PUFA markers and low v. high n-6:n-3 ratios
were protective against depression (EPA: OR 0·92 (95 % CI
0·86, 0·99); DHA: OR 0·96 (95 % CI 0·93, 0·99); DPA:
OR 0·87 (95 % CI 0·77, 0·99); total n-3: OR 0·98 (95 % CI
0·96, 0·99); total n-6:n-3: OR 1·40 (95 % CI 1·09, 1·79)(51).
This study received a high risk of bias score in the study
attrition domain due to high loss to follow-up with
differences shown on baseline characteristics. They had low
risk of bias in all other domains. Rees et al.(39) in their case–
control study with moderate to low risk of bias found that
among many PUFA biomarkers, high DHA, high total n-3
PUFA and a low n-6:n-3 PUFA ratio were protective
against depression (total n-3: OR 0·21 (95 % CI 0·05, 0·99,
P = 0·05); DHA: OR 0·18 (95 % CI 0·04, 0·88, P= 0·03);
n-6:n-3 ratio: OR 4·69 (95 % CI 1·00, 22·0, P = 0·05).
Markhus et al.(35) in Norway examined a range of PUFA
markers in a small cohort study (n 42) that had high risk of
bias in three domains and low risk of bias in the other
three. Using linear regression, they found an association
between a low omega-3 index in pregnancy and EPDS score
postpartum (β = 0·39; P < 0·01). In their Brazilian cohort,
Teoﬁlo et al.(52) measured both mean TAG and cholesterol
levels (total cholesterol, LDL and HDL) and EPDS scores
each trimester of pregnancy and found that higher HDL
concentration was signiﬁcantly associated with lower risk
of antenatal depression in a linear mixed-effects model
(β =−0·08 (95 % CI −0·157, −0·002); P = 0·04).
Multiple nutrients (Supplementary Appendix S2, Table S4).
The study by Bodnar et al.(40) was the only one to examine a
number of major nutrients simultaneously, and used
principal components analysis to create nutrient groups, or
factors, in an American cohort. They identiﬁed three factors
in women less than 20 weeks pregnant: essential fatty acids,
micronutrients and carotenoids, and used a robust clinical
diagnosis of depression in the second and third trimesters of
pregnancy. They did not ﬁnd statistically signiﬁcant results
after adjustment for covariates, but did ﬁnd a crude
association between carotenoids and depression (unadjusted:
OR 0·40 (95 % CI 0·20, 0·90), P = 0·02; adjusted: OR 0·80
(95 % CI 0·30, 2·10), P = 0·67). Other micronutrients
and essential fatty acids were not protective. This study
had a low risk of bias in all domains except for study
attrition and confounding, due to only 73 % of participants
having full assessment data and not fully accounting for
history of depression. Two other studies examining multiple
micronutrients included Fe and B vitamins, and their results
are thus discussed in their respective nutrient categories.
Discussion
Overall, there is inconsistent evidence for an inﬂuence of
nutritional biomarker levels on perinatal depressive symptoms,
with stronger evidence for certain nutrients. There is also not
enough evidence to conclude that there is no link between
nutrients and perinatal depression. Of twenty-four studies
included, fourteen found protective effects of higher nutrient
levels on perinatal depression, two studies reported higher
nutrient levels were associated with a higher risk of perinatal
depression, and the remaining eight studies found no
association.
For vitamin D, there was inconsistent but stronger evidence
for a protective effect, coming from more and higher-quality
studies. Of ten studies on vitamin D, eight were prospective
cohort studies, six showed signiﬁcant protective effects, six
had sample sizes over 200, and only two were of overall
high risk of bias, one of which did not show any association.
(Risk of bias scores are not meant to be collapsed, as heavy
bias in even one domain can change study results. However,
in the interest of interpretability, the risk of bias scores were
combined into an overall bias assessment for the discussion.
Any studies with high risk of bias in at least one domain
were considered generally high risk of bias, if studies had
low risk of bias in at least three domains with no high risk
8
journals.cambridge.org/jns
D
ow
nl
oa
de
d 
fr
om
 h
tt
ps
:/
/w
w
w
.c
am
br
id
ge
.o
rg
/c
or
e.
 L
on
do
n 
Sc
ho
ol
 o
f H
yg
ie
ne
 &
 T
ro
pi
ca
l M
ed
ic
in
e,
 o
n 
05
 F
eb
 2
01
8 
at
 1
4:
08
:3
4,
 s
ub
je
ct
 to
 th
e 
C
am
br
id
ge
 C
or
e 
te
rm
s 
of
 u
se
, a
va
ila
bl
e 
at
 h
tt
ps
:/
/w
w
w
.c
am
br
id
ge
.o
rg
/c
or
e/
te
rm
s.
 h
tt
ps
:/
/d
oi
.o
rg
/1
0.
10
17
/j
ns
.2
01
7.
58
of bias scores, they were considered to have medium risk of
bias, and studies with low risk of bias in four to six domains
with no high risk of bias scores were considered to have over-
all low risk of bias.) For fats and PUFA there was some evi-
dence for a protective effect, coming from one low risk of
bias, medium-sized cohort study (n 238) examining HDL con-
centrations, and three high risk of bias studies addressing
PUFA levels. Although only one of ﬁve studies examining
Fe and perinatal depression reported a protective association,
it was the only low risk of bias study in the group, a prospect-
ive cohort with sufﬁcient power to detect an association (n
729). The remaining four studies on Fe were cross-sectional
or case–control studies; one with medium sample size (n
365) and medium overall risk of bias and three with low sam-
ple sizes (<200) and high overall risk of bias.
Evidence on other minerals is weak due to single studies
examining each distinct exposure. Three studies examined
Se, Zn and Mg and found protective associations from higher
nutrient levels and perinatal depression despite small sample
sizes, but were of overall high risk of bias. One study with
low risk of bias grouped many nutrients into factors and did
not ﬁnd any effect in adjusted analysis.
The evidence for a link between B vitamins and perinatal
depression is also weak. However, the population source
and/or methodology of studies may not have been suitable
for detecting associations. Three of the four studies on B
vitamins did not report the prevalence of nutrient deﬁciency
and the fourth reported a low prevalence (<5 %). Two were
cohort studies with overall low risk of bias, and two were
cross-sectional and had medium or high risk of bias, one
of which surprisingly found that anaemia protected from
depression.
The weakness of the evidence base on this topic may thus
be attributable to a paucity of studies and to methodological
limitations of existing studies rather than an absence of true
associations. We outline several methodological issues below
which may offer some guidance for undertaking higher-quality
studies in the future. Some practical methodological recom-
mendations for future studies are presented in Table 2.
Exposure measurement
All studies measured nutrient biomarkers in the blood. While
this can only capture a few biomarkers, it is generally a precise
indicator of recent bioavailability. FFQ, on the other hand,
measure whole diets and can thus capture complex synergies
of ingested foods, but are imprecise and suffer from reporting
bias(53). Studies using FFQ were reviewed separately(22). Four
of the studies included in this review used both biomarkers
and FFQ(29,31,32,41), which can potentially provide a more
complete picture of nutritional status. However, only one of
these four studies was of high quality and linked diets to
blood levels. The population of this study showed no nutrient
deﬁciency and the authors found no association with perinatal
depression(41). More high-quality longitudinal studies on peri-
natal depression that measure both speciﬁc nutritional biomar-
kers and overall diets are needed.
The timing of exposure measurement is important for sev-
eral reasons. Pregnancy and breastfeeding will deplete nutrient
levels throughout the perinatal period, and levels measured at
the beginning of pregnancy may thus not be comparable with
nutrient levels around birth, even in the same woman(54).
Measuring all study participants at a similar time during preg-
nancy will remove this problem. Alternatively, one could con-
trol for gestational age at nutrient measurement. Time of
measurement in pregnancy may be particularly important for
water-soluble nutrients as their levels ﬂuctuate more than fat-
soluble ones(55,56). At a population level, however, ﬂuctuations
should not be problematic as long as the timing of measure-
ment is more or less the same in the comparison groups.
Currently, critical times of nutrient depletion have not been
deﬁned and the possible relationship of nutrient losses with
depression is unclear, and therefore it is not possible to deter-
mine whether across studies, different measurement times in
the course of pregnancy and lactation would produce different
results. More fundamentally, given the potential for reverse
causality (depressive symptoms leading to poor self-care and
poor diet, or less time outdoors for vitamin D), it is important
to measure nutritional biomarkers with sufﬁcient lead-time
until depression outcome measurement.
Outcome measurement
Clinical diagnosis of depression is the ‘gold standard’, but it is
time-consuming and requires a trained clinician and is thus
usually not feasible in large population studies(10). Various
screening tools have been developed that show good reliability,
sensitivity and speciﬁcity depending on the cut-off point, and
have been adapted to many different languages and cultural
contexts(57,58). For example, a cut-off point of ≥13 on the
EPDS has been shown to have a sensitivity of 0·91 (95 %
CI 0·84, 0·99) and a speciﬁcity of 0·91 (95 % CI 0·88, 0·94)
for postpartum depression(58). Only two tools exclude all som-
atic symptoms of pregnancy and have been validated speciﬁc-
ally for the perinatal period: the EPDS and the Postpartum
Depression Screening Scale(59). Three (15 %) of the twenty-
four included studies used a clinical interview (sometimes in
combination with a screening tool), and nine (45 %) used
Table 2. Methodological recommendations for future studies
Recommendations on design and methods for future studies
1. Choose study populations with substantial nutrient deficiencies
2. Power studies sufficiently, considering prevalences of nutrient
deficiencies and perinatal depression in the study area
3. Measure nutrient concentrations in blood or urine, and assess dietary
intake to have both precise biochemical measures and to capture a
range of nutrients and complex nutrient synergies
4. Measure both depression and nutrients at several time points to be able
to assess magnitude of change and determine the direction of a
possible causal relationship
5. Measure depression with a sufficient time gap after the nutritional
assessment in line with the expected onset of depression after a
nutritional deficiency
6. Standardise timing of measurements as nutrient concentrations are
likely to fluctuate and generally diminish throughout pregnancy
7. Establish a personal and family history of depression and adjust for this
variable as a potential confounder
9
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the EPDS (one a shortened version), while the remaining eight
(40 %) used tools that may not produce valid results in the
perinatal period.
Having a history of mental disorders (including depression)
is a known risk factor for perinatal depression, and antenatal
depression is a risk factor for postpartum depression(60).
Eleven (55 %) of the twenty-four reviewed studies failed to
take baseline depression or history of depression into account
in their analysis. This can potentially confound the relationship
of interest since previous depressive symptoms are likely to
have a negative inﬂuence on self-care and diets and thus on
nutritional status(61). Failing to account for (recent) depressive
history could thus lead to spurious associations.
Other sources of bias
Many studies included in the present review suffered from
weaknesses in design and reporting, often in more than one
domain. Eleven (55 %) of the studies had limited power to
detect an effect due to small sample size (<200), which
makes null ﬁndings difﬁcult to interpret. In the two case–con-
trol studies and one cross-sectional study that found an asso-
ciation (out of seven with these designs), reverse causality
cannot be ruled out as a possible explanation. The same is
true for some cohort studies where lag time between exposure
and outcome measurement was very short, the lowest being 3
weeks(46).
The large cohorts generally described enrolment and
follow-up protocols in detail (such as Blunden et al.(41) and
Cassidy-Bushrow et al.(33)), but several of the other studies
did not (such as Pinto et al.(51)), making it difﬁcult to judge
risk of bias. Thirteen studies (54 %) did not include important
potential confounders, such as basic sociodemographic vari-
ables, and thus may have overestimated the strength of the
association. In the special case of vitamin D, the compound
can be ingested through foods or synthesised by the human
body if skin is exposed to sunlight. Sunlight exposure also
has a proposed direct link to depression outside the dietary
intake pathway(62). Hence, any nutritional analysis of vitamin
D should adjust for sunlight exposure or a proxy thereof.
Lastly, statistical model building and reporting was unclear in
some studies, which made it difﬁcult to interpret the results
and assess the evidence.
Most of these studies were observational (since blood nutri-
ent concentrations cannot be directly increased) and suffered
from several limitations, which can explain some inconsisten-
cies in the results. A recent review on the relationship between
dietary intake and supplementation with perinatal depression
similarly found that there was inconclusive evidence of an
association between certain diets and foods with perinatal
depression. The strongest PUFA experimental study in the
previous review found no effect on depression, but other trials
also on PUFA did ﬁnd an association. Taken together, the evi-
dence from both reviews suggests that, although not deﬁnitive,
higher v. lower concentrations of PUFA may be protective
against depression(22), but would require further investigation.
Most trials focus on one nutrient or supplement combination,
rather than diets as a whole. In the previous review on diets
and supplementation, observational studies also generally
found a protective effect from healthier or Mediterranean
diets as a whole(22).
Prevalence of nutritional deficiency
Sixteen of twenty-four studies included in the present review are
from high-income countries where nutrient deﬁciencies are rela-
tively rare(56). Three others were undertaken in Turkey, Brazil
and Iran, which are upper-middle-income countries(37,48,52),
and one study came from India, a lower-middle-income coun-
try(29). In higher-income settings, there may be insufﬁcient vari-
ation in nutrient levels and too few participants in the clinically
deﬁcient range to detect an association. For example, Blunden
et al.(41) reported no associations with perinatal depression when
examining folate in a setting where 96 % of the women
reported taking folic acid supplements during pregnancy, and
the prevalence of folate deﬁciency was below 5 %. Studies
from low-income countries, where nutritional deﬁciencies are
still widespread and more severe, would therefore have a
much better chance to establish this relationship(2,5).
Vitamin D deﬁciency is common in many populations
around the world, including in high-income countries(63).
Insufﬁciency in the study populations of the reviewed articles
ranged from 24 %(43) to 85 %(44). Higher prevalence of deﬁ-
ciency provided more power to detect an association with peri-
natal depression, and indeed, for vitamin D, the evidence of an
association with perinatal depression was most convincing.
There is also evidence in the literature of an association
between vitamin D and depression in general, i.e. not just in
the perinatal period(64).
Practical implications
While there is an emerging body of evidence on the treatment
of perinatal depression with PUFA(65), there has been little
research so far on prevention. Prevention strategies can be
broader than treatment strategies, as they work ‘upstream’ of
the problem and can address several risk factors and outcomes
concomitantly. The Lancet series on perinatal mental health in
2014 highlighted risk factors for perinatal depression including
low socio-economic status, trauma, domestic violence, lack of
support, migration status, history of psychopathology, and
chronic illness and medical problems(66). Some treatment
options (and to a lesser extent prevention strategies) proposed
in LMIC are embedded within complex interventions that have
health and economic components related to nutrition(13,66).
Understanding the root causes of perinatal depression, includ-
ing the role of nutrition, may encourage a shift from treatment
to prevention, and targeting these root causes might simultan-
eously alleviate other adverse health outcomes. Developing
prevention strategies could also reduce the need for treatment
options, which are often inaccessible to women in LMIC(67).
Strengths and limitations
We gathered all available evidence on whether blood levels of
different nutrients are associated with perinatal depression. We
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considered both antenatal and postpartum depression, which
traditionally have been separated(8,30). Previously, the focus
has been on postpartum depression, but evidence is emerging
that antenatal depression is both common unto itself and a risk
factor for postpartum depression(68–70) and should thus no
longer be ignored. Because of the heterogeneity of both the
exposure and the outcome classiﬁcation, a meta-analysis was
not possible, but we provide a narrative synthesis of evidence
on the topic.
A limitation of the present review is that it may suffer from
publication bias. Studies ﬁnding null results are less likely to be
published in English-language scientiﬁc journals and we did
not include other languages or grey literature. However, we
did identify six studies that reported no signiﬁcant associations
(B vitamins, vitamin D, Fe, and all nutrients grouped in prin-
cipal components analysis) and two studies that reported high
nutrient levels (B vitamins) or anaemia as risk factors for peri-
natal depression, contrary to expectation. Furthermore, there
may be many more unknown relationships between nutrients
other than those in the present review and perinatal depres-
sion, which have yet to be examined and thus are not part
of this synthesis.
Conclusions
This synthesis of available evidence suggests that blood levels
of certain nutrients potentially play a role in the development
of perinatal depression, but results are inconsistent and we lack
conﬁdence in effect estimates. The evidence appears to be
stronger for vitamin D compared with B vitamins or minerals.
However, many studies exhibited serious methodological lim-
itations, and in several nutrient categories only one study of
poor quality was available, reducing the ability to draw robust
conclusions. These ﬁndings are similar to what we found when
reviewing studies on the inﬂuence of dietary intake and supple-
mentation on perinatal depression. While overall inconclusive,
there was some evidence that perinatal depression is linked to
certain diets and foods(22). To strengthen the evidence base on
this topic, robust longitudinal studies are needed from settings
with higher prevalence of nutritional deﬁciencies that ideally
measure both speciﬁc nutritional biomarkers and overall diets.
Supplementary material
The supplementary material for this article can be found at
https://doi.org/10.1017/jns.2017.58
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